Molly Henderson - 01 Nov 2023 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
CFO and CBO
Signature
/s/ Larry Miller, Attorney-in-Fact for Molly Henderson
Issuer symbol
PHAT
Transactions as of
01 Nov 2023
Net transactions value
-$110,871
Form type
4
Filing time
03 Nov 2023, 16:55:17 UTC
Previous filing
21 Jul 2023
Next filing
21 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Award $0 +22,500 +24% $0.000000 117,680 01 Nov 2023 Direct F1
transaction PHAT Common Stock Sale $6,326 -811 -0.69% $7.80 116,869 01 Nov 2023 Direct F2
transaction PHAT Common Stock Sale $104,545 -11,681 -10% $8.95 105,188 01 Nov 2023 Direct F2
holding PHAT Common Stock 1,134 01 Nov 2023 By 401(k)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned with respect to a performance stock unit award granted on January 19, 2023 that contained a performance-vesting requirement that was satisfied on November 1, 2023.
F2 Represents shares sold to satisfy tax withholding obligations upon the settlement of performance stock units.